References
Key articles
Centers for Disease Control and Prevention. Viral hepatitis: hepatitis E. Jun 2020 [internet publication].Full text
European Association for the Study of the Liver. EASL clinical practice guidelines on hepatitis E virus infection. J Hepatol. 2018 Jun;68(6):1256-71.Full text Abstract
Public Health England. Hepatitis E: symptoms, transmission, treatment and prevention. May 2020 [internet publication].Full text
Miller JM, Binnicker MJ, Campbell S, et al; Infectious Diseases Society of America and the American Society for Microbiology. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018 Aug 31;67(6):e1-94.Full text Abstract
Reference articles
1. Centers for Disease Control and Prevention. Viral hepatitis: hepatitis E. Jun 2020 [internet publication].Full text
2. European Association for the Study of the Liver. EASL clinical practice guidelines on hepatitis E virus infection. J Hepatol. 2018 Jun;68(6):1256-71.Full text Abstract
3. Lhomme S, Marion O, Abravanel F, et al. Clinical manifestations, pathogenesis and treatment of hepatitis E virus infections. J Clin Med. 2020 Jan 24;9(2):331.Full text Abstract
4. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008 Feb 21;358(8):811-7.Full text Abstract
5. Marion O, Abravanel F, Lhomme S, et al. Hepatitis E in transplantation. Curr Infect Dis Rep. 2016 Mar;18(3):8. Abstract
6. Smith DB, Simmonds P, members of the International Committee On The Taxonomy Of Viruses Study Group, et al. Consensus proposals for classification of the family Hepeviridae. J Gen Virol. 2014 Oct;95(pt 10):2223-32.Full text Abstract
7. Labrique AB, Zaman K, Hossain Z, et al. Epidemiology and risk factors of incident hepatitis E virus infections in rural Bangladesh. Am J Epidemiol. 2010 Oct 15;172(8):952-61.Full text Abstract
8. Lee GH, Tan BH, Teo EC, et al. Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk. Gastroenterology. 2016 Feb;150(2):355-7.e3.Full text Abstract
9. Pischke S, Hartl J, Pas SD, et al. Hepatitis E virus: infection beyond the liver? J Hepatol. 2017 May;66(5):1082-95. Abstract
10. Patra S, Kumar A, Trivedi SS, et al. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med. 2007 Jul 3;147(1):28-33. Abstract
11. Kumar Acharya S, Kumar Sharma P, Singh R, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol. 2007 Mar;46(3):387-94. Abstract
12. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med. 2012 Sep 27;367(13):1237-44. Abstract
13. Suneetha PV, Pischke S, Schlaphoff V, et al. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology. 2012 Mar;55(3):695-708. Abstract
14. Kmush BL, Labrique AB, Dalton HR, et al. Two generations of "Gold Standards": the Impact of a decade in hepatitis E virus testing innovation on population seroprevalence. Am J Trop Med Hyg. 2015 Oct;93(4):714-7.Full text Abstract
15. World Health Organization. Fact sheets: hepatitis E. Jul 2023 [internet publication].Full text
16. Li P, Liu J, Li Y, et al. The global epidemiology of hepatitis E virus infection: a systematic review and meta-analysis. Liver Int. 2020 Jul;40(7):1516-28.Full text Abstract
17. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet. 2012 Jun 30;379(9835):2477-88. Abstract
18. Oeser C, Vaughan A, Said B, et al. Epidemiology of hepatitis E in England and Wales: a 10-year retrospective surveillance study, 2008-2017. J Infect Dis. 2019 Jul 31;220(5):802-10.Full text Abstract
19. Meng XJ, Wiseman B, Elvinger F, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol. 2002 Jan;40(1):117-22.Full text Abstract
20. Teshale EH, Denniston MM, Drobeniuc J, et al. Decline in hepatitis E virus antibody prevalence in the United States from 1988-1994 to 2009-2010. J Infect Dis. 2015 Feb 1;211(3):366-73.Full text Abstract
21. Adlhoch C, Avellon A, Baylis SA, et al. Hepatitis E virus: assessment of the epidemiological situation in humans in Europe, 2014/15. J Clin Virol. 2016 Sep;82:9-16.Full text Abstract
22. Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014 Nov 15;384(9956):1766-73.Full text Abstract
23. Bura M, Łagiedo M, Michalak M, et al. Hepatitis E virus IgG seroprevalence in HIV patients and blood donors, west-central Poland. Int J Infect Dis. 2017 Aug;61:20-2.Full text Abstract
24. Ijaz S, Vyse AJ, Morgan D, et al. Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol. 2009 Apr;44(4):272-6. Abstract
25. British Transplantation Society. Guidelines for hepatitis E and solid organ transplantation. First edition. Apr 2017 [internet publication].Full text
26. Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 1983;20(1):23-31. Abstract
27. Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 1990 Mar 16;247(4948):1335-9. Abstract
28. Said B, Ijaz S, Kafatos G, et al. Hepatitis E outbreak on cruise ship. Emerg Infect Dis. 2009 Nov;15(11):1738-44.Full text Abstract
29. Chaussade H, Rigaud E, Allix A, et al. Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals. J Clin Virol. 2013 Nov;58(3):504-8. Abstract
30. Cheung CKM, Wong SH, Law AWH, et al. Transfusion-transmitted hepatitis E: what we know so far? World J Gastroenterol. 2022 Jan 7;28(1):47-75.Full text Abstract
31. Slavov SN, Maçonetto JDM, Martinez EZ, et al. Prevalence of hepatitis E virus infection in multiple transfused Brazilian patients with thalassemia and sickle cell disease. J Med Virol. 2019 Sep;91(9):1693-7. Abstract
32. Public Health England. Hepatitis E: symptoms, transmission, treatment and prevention. May 2020 [internet publication].Full text
33. Ushiro-Lumb I, Forsythe J, Haywood B, et al. Impact of hepatitis E virus screening in the UK deceased organ donor population. Transpl Int. 2023 Sep 4;36:11673.Full text Abstract
34. Kumar RM, Uduman S, Rana S, et al. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol. 2001 Dec 10;100(1):9-15. Abstract
35. Marion O, Lhomme S, Nayrac M, et al. Hepatitis E virus replication in human intestinal cells. Gut. 2020 May;69(5):901-10. Abstract
36. Wu JC, Sheen IJ, Chiang TY, et al. The impact of traveling to endemic areas on the spread of hepatitis E virus infection: epidemiological and molecular analyses. Hepatology. 1998 May;27(5):1415-20.Full text Abstract
37. Clayson ET, Shrestha MP, Vaughn DW, et al. Rates of hepatitis E virus infection and disease among adolescents and adults in Kathmandu, Nepal. J Infect Dis. 1997 Sep;176(3):763-6.Full text Abstract
38. Péron JM. Hepatitis E virus infection and cirrhosis of the liver. Gastroenterol Hepatol (N Y). 2016 Sep;12(9):565-7.Full text Abstract
39. Gouilly J, Chen Q, Siewiera J, et al. Genotype specific pathogenicity of hepatitis E virus at the human maternal-fetal interface. Nat Commun. 2018 Nov 12;9(1):4748.Full text Abstract
40. Tsega E, Krawczynski K, Hansson BG, et al. Outbreak of acute hepatitis E virus infection among military personnel in northern Ethiopia. J Med Virol. 1991 Aug;34(4):232-6. Abstract
41. Te H, Doucette K. Viral hepatitis: guidelines by the American Society of Transplantation Infectious Disease Community of Practice. Clin Transplant. 2019 Sep;33(9):e13514. Abstract
42. Huang S, Zhang X, Su Y, et al. Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2024 Feb 19 [Epub ahead of print]. Abstract
43. Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010 Sep 11;376(9744):895-902. Abstract
44. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007 Mar 1;356(9):895-903.Full text Abstract
45. Boland F, Martinez A, Pomeroy L, et al. Blood donor screening for hepatitis E virus in the European Union. Transfus Med Hemother. 2019 Apr;46(2):95-103.Full text Abstract
46. Kamani L, Padhani ZA, Das JK. Hepatitis E: genotypes, strategies to prevent and manage, and the existing knowledge gaps. JGH Open. 2021 Oct;5(10):1127-34.Full text Abstract
47. Chandra NS, Sharma A, Malhotra B, et al. Dynamics of HEV viremia, fecal shedding and its relationship with transaminases and antibody response in patients with sporadic acute hepatitis E. Virol J. 2010 Sep 6;7:213.Full text Abstract
48. Gérolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med. 2008 Feb 21;358(8):859-60.Full text Abstract
49. Pischke S, Stiefel P, Franz B, et al. Chronic hepatitis E in heart transplant recipients. Am J Transplant. 2012 Nov;12(11):3128-33.Full text Abstract
50. Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines. Am J Gastroenterol. 2023 Jul 1;118(7):1128-53.Full text Abstract
51. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Shaffner F (eds). Progress in liver diseases. 3rd ed. New York, NY: Grune & Stratton; 1970:282-98. Abstract
52. Gimson AE, O'Grady J, Ede RJ, et al. Late onset hepatic failure: clinical, serological and histological features. Hepatology. 1986 Mar-Apr;6(2):288-94.Full text Abstract
53. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 1986 May;6(2):97-106. Abstract
54. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011 May;140(5):1481-9.Full text Abstract
55. Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014 Aug;60(2):715-35.Full text Abstract
56. Miller JM, Binnicker MJ, Campbell S, et al; Infectious Diseases Society of America and the American Society for Microbiology. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018 Aug 31;67(6):e1-94.Full text Abstract
57. Kamar N, Rostaing L, Abravanel F, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology. 2010 Nov;139(5):1612-8.Full text Abstract
58. Kovvuru K, Carbajal N, Pakanati AR, et al. Renal manifestations of hepatitis E among immunocompetent and solid organ transplant recipients. World J Hepatol. 2022 Mar 27;14(3):516-24.Full text Abstract
59. Dalton HR, Fellows HJ, Stableforth W, et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther. 2007 Nov 15;26(10):1429-35.Full text Abstract
60. Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020 Aug;72(2):671-722.Full text Abstract
61. Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006 Jan 5;354(1):54-66. Abstract
62. Péron JM, Dalton H, Izopet J, et al. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? J Hepatol. 2011 Jun;54(6):1323-4; author reply 1324-5.Full text Abstract
63. Martin P, DiMartini A, Feng S, et al. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014 Mar;59(3):1144-65.Full text Abstract
64. Gorris M, van der Lecq BM, van Erpecum KJ, et al. Treatment for chronic hepatitis E virus infection: a systematic review and meta-analysis. J Viral Hepat. 2021 Mar;28(3):454-63.Full text Abstract
65. Pischke S, Hardtke S, Bode U, et al. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int. 2013 May;33(5):722-6. Abstract
66. Mallet V, Nicand E, Sultanik P, et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med. 2010 Jul 20;153(2):85-9.Full text Abstract
67. Kamar N, Izopet J, Tripon S, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med. 2014 Mar 20;370(12):1111-20.Full text Abstract
68. Hajji H, Gérolami R, Solas C, et al. Chronic hepatitis E resolution in a human immunodeficiency virus (HIV)-infected patient treated with ribavirin. Int J Antimicrob Agents. 2013 Jun;41(6):595-7. Abstract
69. Neukam K, Barreiro P, Macías J, et al. Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clin Infect Dis. 2013 Aug;57(3):465-8.Full text Abstract
70. Tavitian S, Peron JM, Huguet F, et al. Ribavirin for chronic hepatitis prevention among patients with hematologic malignancies. Emerg Infect Dis. 2015 Aug;21(8):1466-9.Full text Abstract
Use of this content is subject to our disclaimer